Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a small molecule organic chemical classified as an anisole derivative, containing a methoxybenzene moiety linked via a hexyl chain to an imidazole ring. Its molecular formula is C16H21ClN2O2 with a molecular weight of approximately 308.8 g/mol. The IUPAC name is 1-[6-(2-chloro-4-methoxyphenoxy)hexyl]-1H-imidazole. There is limited publicly available information on its pharmacological mechanism of action or therapeutic indications, and it appears to be primarily experimental without established clinical use or approved indications. It may have been studied in research contexts but lacks detailed data on targets or clinical development status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-[6-(2-chloro-4-methoxyphenoxy)-hexyl]-imidazole.